Biogen reanalyzes studies, presses ahead on Alzheimer's drug

Vegas, Inc.

Oct 22, 2019

Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of th…